 | • レポートコード：MRC2307A0230 • 出版社/出版日：Transparency Market Research / 2023年5月 • レポート形態：英文、PDF、167ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査資料によると、世界の植込み型除細動器市場規模は2023年の36億ドルから2031年には58億ドルへ上り、予想期間中、年平均5.6％拡大すると予測されています。本調査資料では、植込み型除細動器の世界市場を調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、製品別（経静脈的植込み型除細動器（T-ICD）、皮下植込み型除細動器（S-ICD））分析、エンドユーザー別（病院・診療所、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などについて明らかにしています。なお、本書に記載されている企業情報には、Boston Scientific Corporation、BIOTRONIK、Medtronic、LivaNova、Abbott、MicroPortなどが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要洞察 ・世界の植込み型除細動器市場規模：製品別 - 経静脈的植込み型除細動器（T-ICD）の市場規模 - 皮下植込み型除細動器（S-ICD）の市場規模 ・世界の植込み型除細動器市場規模：エンドユーザー別 - 病院・診療所における市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の植込み型除細動器市場規模：地域別 - 北米の植込み型除細動器市場規模 - ヨーロッパの植込み型除細動器市場規模 - アジア太平洋の植込み型除細動器市場規模 - 中南米の植込み型除細動器市場規模 - 中東・アフリカの植込み型除細動器市場規模 ・競争状況 |
Implantable Cardioverter Defibrillator Market – Scope of Report
TMR’s report on the global Implantable Cardioverter Defibrillator market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Implantable Cardioverter Defibrillator market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Implantable Cardioverter Defibrillator market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Implantable Cardioverter Defibrillator market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Implantable Cardioverter Defibrillator market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Implantable Cardioverter Defibrillator market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Implantable Cardioverter Defibrillator market.
The report delves into the competitive landscape of the global Implantable Cardioverter Defibrillator market. Key players operating in the global Implantable Cardioverter Defibrillator market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Implantable Cardioverter Defibrillator market profiled in this report.
Key Questions Answered in Global Implantable Cardioverter Defibrillator Market Report
• What is the sales/revenue generated by Implantable Cardioverter Defibrillator across all regions during the forecast period?
• What are the opportunities in the global Implantable Cardioverter Defibrillator market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Implantable Cardioverter Defibrillator Market – Research Objectives and Research Approach
The comprehensive report on the global Implantable Cardioverter Defibrillator market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Implantable Cardioverter Defibrillator market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Implantable Cardioverter Defibrillator market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Implantable Cardioverter Defibrillator Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Regulatory Scenario by Region/globally
5.3. Key Product/Brand Analysis
5.4. COVID-19 Pandemics Impact on Industry
6. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
6.3.1.1. Cardiac Resynchronization Therapy (CRT)
6.3.1.2. Dual Chamber ICDs
6.3.1.3. Single Chamber ICDs
6.3.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
6.4. Market Attractiveness Analysis, by Product
7. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals & Clinics
7.3.2. Ambulatory Surgery Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Implantable Cardioverter Defibrillator Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017-2031
9.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
9.2.1.1. Cardiac Resynchronization Therapy (CRT)
9.2.1.2. Dual Chamber ICDs
9.2.1.3. Single Chamber ICDs
9.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals & Clinics
9.3.2. Ambulatory Surgery Centers
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Implantable Cardioverter Defibrillator Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
10.2.1.1. Cardiac Resynchronization Therapy (CRT)
10.2.1.2. Dual Chamber ICDs
10.2.1.3. Single Chamber ICDs
10.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals & Clinics
10.3.2. Ambulatory Surgery Centers
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Implantable Cardioverter Defibrillator Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
11.2.1.1. Cardiac Resynchronization Therapy (CRT)
11.2.1.2. Dual Chamber ICDs
11.2.1.3. Single Chamber ICDs
11.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals & Clinics
11.3.2. Ambulatory Surgery Centers
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Implantable Cardioverter Defibrillator Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
12.2.1.1. Cardiac Resynchronization Therapy (CRT)
12.2.1.2. Dual Chamber ICDs
12.2.1.3. Single Chamber ICDs
12.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Hospitals & Clinics
12.3.2. Ambulatory Surgery Centers
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Implantable Cardioverter Defibrillator Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
13.2.1.1. Cardiac Resynchronization Therapy (CRT)
13.2.1.2. Dual Chamber ICDs
13.2.1.3. Single Chamber ICDs
13.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals & Clinics
13.3.2. Ambulatory Surgery Centers
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Boston Scientific Corporation
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. BIOTRONIK
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Medtronic
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. LivaNova
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Abbott
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. MicroPort
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
Table 01: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
Table 02: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 03: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Region, 2017-2031
Table 04: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
Table 05: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 06: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country, 2017-2031
Table 07: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
Table 08: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 09: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
Table 11: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 12: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 13: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
Table 14: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 15: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 16: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
Table 17: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
Table 18: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031